ENDEXX Corp. (OTCMKTS:EDXC) reported the launch of two new offerings from its Phyto Labs segment. The preliminary offering line Amrita™ is intended at enhancing recovery and energy and provides formulas for 4 uniquely flavored Cannabidiol beverages. The company has also introduced Nightcaps©.
Todd Davis, the CEO of ENDEXX, reported that they are delighted to be launching new offerings from their premium CBD line. Following the acquisition deal of Phyto Labs, the company has spent a notable time in R&D and consider they are developing premium products that benefit their consumers in improving their wellness, health and overall lifestyle. The biofeedback by both clients and patients has been extraordinary and sustains to lead preliminary product adoption and success.
The company bought Phyto in March 2017. Each product advanced has been thoroughly assessed and tested in a medical and clinical environment. The ingredients have been evaluated to perform therapeutically and advance health and wellness measurably. Currently, there are numerous offerings in the pipeline that are in last phases of development for launch to Endexx’s retail and commercial clientele. New products can be seen at the new site www.phyto-labs.com
Endexx provides innovative technology and inventory management solutions. The company, with its collaborative associates and consultants, develops and supplies two consumable product lines got from industrial hemp, which is naturally rich and organic in phytocannabinoids. Phyto-Bites® is its cannabinoid-infused soft chews for dogs.
The treats are formulated to enhance health and support the decline of separation anxiety, inflammation and pain. Endexx also possesses two technology services and products that were introduced in 2014 — the Autospense™ and the M3hub.
Both products offer essential solutions to support regulatory compliance and full accountability via seed-to-sale inventory management as well as End-of-Sale technology integration. Grounded on principles advanced by the pharmacological market, the m3hub platform marks as the first standardized software offering for tracking pharmaceutical grade pot that maintains compliance with state, local and federal regulations.